CRISIL Monitoring Report on Tilaknagar Industries Preferential Issue Proceeds
Tilaknagar Industries Ltd 路 Others (Uncategorized) 路 02 Nov 2026, 7:54 pm
CRISIL Monitoring Report on Tilaknagar Industries Preferential Issue Proceeds Tilaknagar Industries utilized no preferential issue proceeds during the quarter ended 30th Sep'26, with cumulative utilization standing at Rs 2,093.07 crore out of the total Rs 2,295.63 crore issue size. Historically, deployed funds include Rs 1,296.78 crore for brand acquisition (Imperial Blue from Pernod Ricard), Rs 499.49 crore for working capital, and Rs 296.80 crore for general corporate purposes. The unutilized balance of Rs 202.56 crore represents pending warrant conversion receivables due from promoters on or before Mar'27, with no deviations reported.
Original exchange filing (PDF)
More announcements from Tilaknagar Industries Ltd
- Pursuant to Reg 30 of SEBI LODR we wish to inform you that the Directorate of Revenue Intelligence Mumbai Zonal Unit issued a seizure memo under the provisions of Section 110 of the Customer .... 路 06 Nov 2026
- Transcript of earnings conference call held for Q2 FY 2024 results. 路 06 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we wish to inform you that the management shall be interacting with analyst/investors .... 路 05 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform that the management shall be interacting with analyst/investors .... 路 05 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the management shall be interacting with analyst/ investors .... 路 05 Nov 2026
- Audio Recording of earnings call held for Q2 FY 27 results 路 01 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 , we wish to inform you that the management shall be interacting with analyst/investors .... 路 31 Oct 2026
- Cessation of Maj Gen Dr. Dilawar Singh (Retd) and Mr. Satish Chand Mathur as Independent Directors of the Company upon completion of their second term with effect from the close of business .... 路 31 Oct 2026
